Page 1520 · TIME wound-bed prep, debridement, multi-layer compression, moisture-balanced dressings, and healing trajectory for venous leg ulcers
Venous leg ulcers arise from chronic venous hypertension: incompetent calf-muscle-pump valves allow ambulatory venous pressure to stay elevated, driving fibrin cuffing around capillaries, leukocyte trapping, and progressive dermal and subcutaneous tissue breakdown over the medial malleolus — the "gaiter" region where perforator veins are most concentrated. Before any treatment plan is chosen, a structured assessment establishes that the ulcer is truly venous in origin and that the limb can safely tolerate compression, the cornerstone therapy for this condition.
Venous leg ulcers are the end-stage manifestation of chronic venous insufficiency (CVI). When valves in the deep, superficial, or perforator veins fail — from prior DVT, primary valvular weakness, or calf-muscle-pump dysfunction — venous pressure that should fall during walking instead stays elevated (ambulatory venous hypertension).
Sustained capillary hypertension widens endothelial pores, allowing fibrinogen and macromolecules to leak into the dermis. Fibrinogen polymerizes into pericapillary "fibrin cuffs" that were once thought to block oxygen diffusion directly; contemporary evidence instead implicates trapped leukocytes releasing proteases and inflammatory mediators, and TGF-β1-driven fibrosis, producing lipodermatosclerosis, hemosiderin staining, and eventually skin breakdown — most often just above the medial malleolus, where the perforator density and hydrostatic pressure are greatest.
Once the skin breaks down, the ulcer tends to persist because the driving pressure abnormality is still present: healing a venous ulcer without correcting venous hypertension is like mopping a floor without turning off the tap.
TIME is a structured, internationally adopted mnemonic for systematically preparing a chronic wound bed to progress toward healing:
• T — Tissue: is the wound bed viable (red granulation, pink epithelium) or nonviable (yellow slough, black eschar)? Nonviable tissue is a physical and biochemical barrier to healing and must be removed.
• I — Infection/Inflammation: distinguish colonization (expected, not harmful) from critical colonization or infection (increasing pain, malodor, friable tissue, periwound erythema, delayed healing). Elevated bioburden prolongs the inflammatory phase and consumes growth factors.
• M — Moisture balance: dry wounds desiccate and slow epithelial migration; over-wet wounds macerate the periwound skin. The dressing must be matched to exudate volume.
• E — Edge of wound: a healing edge shows advancing epithelium; a non-advancing, undermined, or rolled (epibole) edge signals a stalled wound requiring re-evaluation of the whole plan — often biopsy if present >12 weeks despite optimal therapy, to exclude malignant transformation (Marjolin's ulcer).
TIME is revisited at every dressing change, not performed once — the wound bed changes weekly and the plan should change with it.
Compression bandaging is the single most effective intervention for venous ulcers — but it is dangerous, potentially limb-threatening, in a patient with significant coexisting peripheral arterial disease (PAD). Firm compression on a leg with inadequate arterial inflow can cause tissue ischemia, new ulceration, or even gangrene.
The ankle-brachial index (ABI) — systolic pressure at the ankle divided by systolic pressure at the brachial artery, measured by handheld Doppler — is the standard screening test performed before compression is prescribed:
• ABI 0.8–1.3: arterial supply adequate; full compression (30–40mmHg) is safe and recommended • ABI 0.5–0.8: arterial disease present; reduced/modified compression (typically 15–25mmHg) under specialist supervision • ABI <0.5: severe arterial disease; compression is contraindicated — refer for vascular assessment • ABI >1.3: may indicate non-compressible, calcified vessels (common in diabetes) — toe-brachial index or other imaging needed
This single measurement is the gatekeeper that determines whether the entire venous ulcer protocol can proceed as planned.
Never apply high-compression bandaging to a leg with unmeasured or unsafe ABI. Confirming ABI >0.8 before compression is the single most important safety check in the venous ulcer pathway — skipping it risks converting a healable venous wound into a limb-threatening arterial one.
A venous ulcer covered in yellow fibrinous slough or adherent necrotic tissue cannot progress through the normal phases of healing: the devitalized tissue is a physical barrier to epithelial migration, a nutrient source for bacteria, and a trigger that keeps the wound locked in a prolonged, non-productive inflammatory phase. Debridement — the deliberate removal of this nonviable material — is what converts a static, chronic wound into an acute-like wound capable of granulating and closing.
Four debridement approaches are used, often in combination, depending on wound characteristics, pain tolerance, clinician training, and available resources:
• Sharp/surgical debridement: a scalpel, curette, or scissors are used at the bedside or in theatre to excise slough and necrotic tissue down to bleeding, viable tissue. Fastest and most effective method; requires trained personnel and is used cautiously near tendon, bone, or when significant arterial compromise is suspected.
• Autolytic debridement: the body's own enzymes and moisture are harnessed by applying a moisture-retentive dressing (hydrogel, hydrocolloid) that softens and lifts slough over days. Slowest but essentially painless and appropriate for smaller amounts of nonviable tissue or patients who cannot tolerate sharp methods.
• Enzymatic debridement: topical proteolytic enzyme preparations (e.g., collagenase) selectively digest necrotic collagen while sparing viable tissue; used when sharp debridement is unavailable or contraindicated.
• Mechanical debridement: wet-to-dry gauze, low-frequency ultrasound, or monofilament fiber pads physically lift loose slough; largely superseded by more selective methods but still used for gross debris removal.
Most venous ulcer protocols combine an initial sharp debridement session (to rapidly reduce bioburden) with ongoing autolytic debridement maintained through dressing selection between visits.
Chronic wounds are colonized by polymicrobial biofilm communities that are far more tolerant of antiseptics and antibiotics than free-floating (planktonic) bacteria. This biofilm continuously sheds inflammatory stimuli — lipopolysaccharide, peptidoglycan fragments, bacterial proteases — that keep neutrophils and macrophages activated indefinitely, consuming growth factors (PDGF, VEGF, TGF-β) that would otherwise drive fibroblast proliferation and angiogenesis.
Debridement physically disrupts this biofilm and the necrotic scaffold it lives on. Sharp debridement in particular has been shown to reduce surface bacterial load by more than 90% in a single session and to reset the wound's biological clock — converting a stalled chronic wound back toward an acute-wound-like inflammatory response that resolves rather than persists. Wounds debrided regularly (weekly sharp debridement in clinical trials) heal significantly faster than those managed with dressings alone.
A wound bed that is more than roughly 50% covered in slough or eschar should not be considered "moisture-balanced" or ready for advanced dressings — debridement takes priority, because no dressing formulation can compensate for a devitalized wound bed.
Graduated compression — highest pressure at the ankle, tapering toward the knee — directly counteracts the ambulatory venous hypertension that causes venous ulcers in the first place. Applied as a multi-layer bandage system delivering roughly 30–40mmHg at the ankle, compression is supported by decades of randomized trial evidence as the single most important intervention for venous ulcer healing, more influential on outcome than any specific dressing choice.
Compression bandaging works through several complementary mechanisms:
• External counter-pressure reduces the diameter of superficial veins, decreasing venous reflux and improving the effectiveness of the residual functioning valves.
• Graduated pressure — highest at the ankle (30–40mmHg), lower at the calf, lowest below the knee — creates a pressure gradient that assists venous return toward the heart, working with rather than against normal flow physiology.
• Compression augments the calf-muscle pump: with the tissue held firmly, each step generates a more effective ejection of venous blood upward, similar to squeezing a partially-collapsed tube.
• Reduced capillary hydrostatic pressure decreases the transcapillary fluid leak responsible for edema, in turn easing the interstitial burden that impairs oxygen and nutrient diffusion into the wound bed.
The result is a substantial, well-documented improvement in healing rates: multiple systematic reviews (Cochrane) confirm venous ulcers heal faster and more completely with compression than without, and multi-layer systems outperform single-layer bandages.
A typical four-layer high-compression system (the model most widely studied) combines:
1. Layer 1 — Orthopaedic wool or foam padding: absorbs exudate, redistributes pressure evenly, protects bony prominences (especially the malleoli) from excess focal pressure.
2. Layer 2 — Light conformable bandage (crepe): smooths the wool layer, holds dressings in place, provides minimal compression on its own.
3. Layer 3 — Elastic compression bandage: the primary pressure-generating layer, applied with a specified stretch and overlap to achieve the target sub-bandage pressure at the ankle.
4. Layer 4 — Cohesive outer bandage: locks the system together, prevents slippage over the wear period (typically up to one week), and provides additional graduated compression.
Two-layer and short-stretch (inelastic) systems are viable alternatives, particularly when patients need to self-manage or have highly variable limb shape; inelastic systems generate lower resting pressure but higher "working pressure" during calf-muscle activation, which some patients tolerate better.
Correct application technique (spiral wrap, ~50% overlap, consistent stretch, figure-of-eight at the ankle) is as important as the materials themselves — under-application under-treats the ulcer, and over-application in an ABI-compromised limb can cause ischemic injury.
ABI 0.8–1.3 → full high compression 30–40mmHg is appropriate. ABI 0.5–0.8 → reduced compression (~15–25mmHg) under specialist guidance. ABI <0.5 → compression is contraindicated; refer to vascular surgery. Reassess ABI periodically, since arterial status can change over the treatment course.
Once the wound bed has been debrided and compression addresses the underlying venous hypertension, the dressing applied directly to the wound plays a supporting but still important role: maintaining a moist (not wet, not dry) wound environment that favors autolytic debridement, cell migration, and angiogenesis, while managing exudate so the periwound skin is protected and the compression bandage above it is not saturated prematurely.
Moist wound healing theory (Winter, 1962) established that wounds kept moist re-epithelialize roughly twice as fast as those left to dry and form a scab. In practice, the goal is a moisture balance, not maximal moisture — exudate volume determines which dressing category is appropriate:
• Low exudate: hydrogel or thin hydrocolloid — donates or retains moisture without absorbing much, supports autolytic debridement of any residual slough.
• Moderate exudate: foam dressings — highly absorbent, cushioning, comfortable under compression, maintain a moist surface while wicking excess fluid away from the wound bed and periwound skin.
• Heavy exudate: calcium alginate or hydrofiber dressings — gel on contact with wound fluid, can absorb many times their weight, ideal immediately after debridement or in heavily exuding ulcers; changed more frequently until exudate decreases.
• Infected/malodorous wounds: silver- or iodine-impregnated versions of the above categories add antimicrobial activity for critically colonized wounds, used for a defined, time-limited course rather than indefinitely.
Because venous ulcers are dressed underneath a compression bandage that may stay in place for up to a week, the dressing must be chosen for the exudate level expected across that entire wear period, not just at the moment of application.
The skin surrounding a venous ulcer is often already compromised by lipodermatosclerosis, hemosiderin staining, and venous eczema, making it unusually vulnerable to further injury from dressing adhesives, excess moisture, or friction:
• Maceration: white, soggy, breaking-down periwound skin from excess moisture trapped against it — usually signals an under-absorptive dressing choice for the exudate volume present; step up to a more absorptive category.
• Excoriation/contact dermatitis: red, itchy, sometimes blistering periwound skin from adhesive sensitivity or irritant exudate — favor non-adherent or silicone-bordered dressings and barrier films/creams on intact periwound skin.
• Dressing "strike-through": exudate visibly soaking through the outer compression bandage before the scheduled change — indicates the absorptive capacity was exceeded and the interval or dressing category needs adjustment.
Because the dressing sits under multiple compression layers, simplicity and reliability are valued over frequent changes: a dressing that will comfortably manage exudate for the full compression wear period (often 5–7 days) is preferred to one that needs daily change and disruption of the bandage system.
The dressing is chosen to serve the compression system, not the other way around — pick the absorptive capacity for the full bandage wear interval, and never let dressing preference justify reducing or delaying the compression pressure that is actually driving the ulcer to heal.
With etiology confirmed, the wound bed debrided, compression correctly applied within a safe ABI window, and exudate managed with an appropriate dressing, the ulcer should show measurable, trackable progress. Serial wound-area measurement provides an early, evidence-based signal of whether the current plan is working — and, once the ulcer has closed, the same compression principle must continue indefinitely to prevent the very high rate of recurrence.
Wound area — measured by tracing, planimetry, or photographic digital measurement — is recorded at baseline and at each subsequent visit. The percent reduction in area achieved by 4 weeks of appropriately delivered therapy is one of the best-validated prognostic indicators in wound care:
• ≥40% area reduction by week 4: strongly predicts healing by 24 weeks; continue the current protocol unchanged.
• <40% area reduction by week 4: predicts a substantially lower probability of healing by 24 weeks on the current plan; prompts reassessment — is compression pressure adequate, is ABI still safe, is the wound bed still shedding slough, is infection present, is patient adherence to compression wear a limiting factor, or does the diagnosis need to be revisited (mixed arterial-venous disease, vasculitis, malignancy)?
This rule of thumb, formalized from cohort data (Margolis et al.), allows clinicians to identify non-responding wounds early — around the one-month mark rather than waiting the full 6-month course — and intervene while there is still time to change the trajectory.
Once the wound bed is granulating and compression is consistently applied, closure proceeds through two overlapping mechanisms: wound contraction (myofibroblasts in the granulation tissue draw wound margins inward, reducing overall area) and epithelialization (keratinocytes migrate centripetally from the wound edge and any residual epithelial islands across the moist granulation surface).
A typical healing venous ulcer under adequate compression shows a roughly exponential-appearing decline in area over the following weeks to months: rapid early reduction as edema resolves and contraction dominates, followed by a slower phase as the remaining epithelial gap closes. Full closure timelines commonly range from 12 to 24 weeks depending on initial ulcer size, duration prior to treatment, and consistency of compression wear; larger, longer-standing ulcers on limbs with borderline ABI take longer and require closer monitoring.
Healing the ulcer does not correct the underlying valvular incompetence and venous hypertension that caused it. Without ongoing management, venous ulcers recur at strikingly high rates — commonly cited at around 70% within 5 years of closure.
Lifelong graduated compression stockings (typically class II, roughly 20–30mmHg equivalent for maintenance, individually fitted) worn during waking hours are the primary recurrence-prevention strategy, shown in trials to reduce recurrence to roughly a quarter of the untreated rate. Where superficial venous reflux is the dominant driver, endovenous ablation (laser, radiofrequency, or foam sclerotherapy) of the incompetent vein — performed after ulcer healing or, increasingly, early in the healing course per the EVRA trial evidence — further reduces recurrence beyond compression stockings alone.
Patient education on stocking adherence, leg elevation when resting, calf-muscle-pump exercise (ankle dorsiflexion, walking), and skin care of the gaiter region are the ongoing maintenance pillars once the acute wound-care protocol has achieved closure.
Closure of the ulcer is not the end of treatment. Because the venous hypertension that caused the wound persists indefinitely, lifelong maintenance compression stockings — not just active-phase bandaging — are what actually prevent the ~70% five-year recurrence rate seen when compression is discontinued after healing.